ICG-124 by ICell Gene Therapeutics for T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia): Likelihood of Approval

Just – Evotec Biologics will focus on developing drug product prototypes from the discovery stage to the launch of first-in-human Phase I clinical trials. Credit:

Phar­ma­ceu­ti­cal ad­ver­tis­ers are spend­ing strong in 2023 so far, notch­ing a 12% in­crease over last year’s first half. While they’re pour­ing bil­lions of dol­lars in­to

Differentiating tardive dyskinesia from other movement disorders can be challenging. “One major criterion is the history of exposure to neuroleptic medications,” said Jeff Bronstein, MD,